Table 2
Experimental features and main data of the previous studies on the role of arachidonic acid in AD. We previously showed the mice in which the expression of the main ARA releasing enzyme cPLA2 has been suppressed, are resistant to the neurotoxicity of the Aβ peptide oligomers. By contrast, an ARA-rich diet increase the sensitivity of the mice to the neurotoxicity of the Aβ peptide oligomers. Two other teams studied the role of dietary ARA and reported conflicting results.
Sources | Main experimental features | Main experimental data |
---|---|---|
Desbène et al., 2012 | cPLA2−/− mice ICV injection of Aβ peptides |
→ cognitive abilities in cPLA2−/− mice → PSD95 and SNP25 in cPLA2−/− mice |
Thomas et al., 2017 | Balb/c mice 1% ARA diet for 12 weeks ICV injection of Aβ peptides |
Learning abilities AMPA Receptors GFAP |
Amtul et al., 2012 | CRND8 mice 2% ARA diet for 21 weeks |
Aβ1–42 production and deposition |
Hosono et al., 2015a, 2015b | Tg2576 mice ARA Supplementation of the diet 4% |
Cognitive alteration Amyloid plaques |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.